Fol. Biol. 2019, 65, 53-63

https://doi.org/10.14712/fb2019065020053

Immune Cells and Immunosenescence

J. Bischof1, F. Gärtner1, K. Zeiser1, R. Kunz1, C. Schreiner1, E. Hoffer1, T. Burster2, U. Knippschild1, Michał Zimecki3

1Department of General Visceral Surgery, Surgery Center, Ulm University Medical Center, Ulm, Germany
2Department of Biology, School of Science and Technology, Nazarbayev University, Astana, Kazakhstan Republic
3Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland

Received October 2018
Accepted December 2018

Aging is associated with progressive loss of physiological integrity, leading to impaired physical and mental functions as well as increased morbidity and mortality. With advancing age, the immune system is no longer able to adequately control autoimmunity, infections, or cancer. The abilities of the elderly to slow down undesirable effects of aging may depend on the genetic background, lifestyle, geographic region, and other presently unknown factors. Although most aspects of the immunity are constantly declining in relation to age, some features are retained, while e.g. the ability to produce high levels of cytokines, response to pathogens by increased inflammation, and imbalanced proteolytic activity are found in the elderly, and might eventually cause harm. In this context, it is important to differentiate between the effect of immunosenescence that is contributing to this decline and adaptations of the immune system that can be quickly reversed if necessary.

Funding

The workgroup of Uwe Knippschild was supported by the DFG (Deutsche Forschungsgemeinschaft) via funding for the collaborative research center 1149 (SFB1149).

References

116 live references